Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 25 Jun 2025

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway

in Molecular and Cellular Oncology

Jinhai Li
Huawei Zhai
Fujing Cai
Xian Zhang
Yu Zhou
Shuqun Li
Huachun Song
Haifeng Zhang
Guangzheng Sun
Minghui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592616

261 views

Original Research

Published on 24 Jun 2025

CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model

in Molecular and Cellular Oncology

Wei Ning
Yan-Ru Yang
Chen-Xu Wu
Yue Hou
Zhi-Wei Liu
Chang-Bin Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564826

418 views

Original Research

Published on 24 Jun 2025

p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation

in Molecular and Cellular Oncology

Xiao Liu
Honglin Qu
Jingmin Li
Xuhong Sun
Zhenlin Wang
Dong Wang
Xianyong Bai
Xiaoyan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1584811

423 views

Correction

Accepted on 23 Jun 2025

Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway

in Molecular and Cellular Oncology

Liujing Qu
Yu XIN
Jieni Feng
Xiaolei Ren
Zuming Li
Xueru CHEN
Guangyan Miao
Jiankun Chen
Chengming Sun
Yue Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1643772

119 views

Original Research

Published on 23 Jun 2025

CD16 and Siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells

in Molecular and Cellular Oncology

Chris D. St. Laurent
Zeinab Jame-Chenarboo
Alyssa E. Beck
Stacey Stubblefield
Shiteng Duan
Darren Sigal
Matthew S. Macauley

Frontiers in Oncology

doi 10.3389/fonc.2025.1570121

399 views

Original Research

Published on 23 Jun 2025

PP1γ promotes esophageal squamous cell carcinoma progression through the PP1γ/YAP1/SOX2 axis

in Molecular and Cellular Oncology

Juan Du
Li Liu
Shutao Zheng
Chenglu Dai
Jingyu Liu
Wei Zhang
Hongwei Pu
Jing Xue

Frontiers in Oncology

doi 10.3389/fonc.2025.1586679

464 views

Original Research

Published on 23 Jun 2025

Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p

in Molecular and Cellular Oncology

Qi Liu
Yong-Kui Yu
Hao-Miao Li
Wei Wang
Jing Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1542742

269 views

Review

Accepted on 20 Jun 2025

“Molecular Pigeon” Network of lncRNA and miRNA: Decoding Metabolic Reprogramming in Patients with Lung Cancer

in Molecular and Cellular Oncology

Mingxiao Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1578927

Original Research

Published on 20 Jun 2025

MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma

in Molecular and Cellular Oncology

Mst Nasrin Akhtar
Annabell Walter
Kathrin Katenkamp
Yuan Chen
Thomas Lehmann
Wolfram Weschenfelder
Christian Spiegel
Matthias Vogt
Gunther O. Hofmann
Andreas Hochhaus

Frontiers in Oncology

doi 10.3389/fonc.2025.1577859

516 views

Review

Published on 19 Jun 2025

Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics

in Molecular and Cellular Oncology

Xiao-Qing Tan
Ai-Ying Guo
Li-Fei Zheng
Jun Xiong

Frontiers in Oncology

doi 10.3389/fonc.2025.1598868

402 views

Case Report

Published on 18 Jun 2025

Case Report: Metastatic colorectal cancer with ALK–CEP44 fusion and rapid resistance development

in Molecular and Cellular Oncology

Silvan Hofmann
Claudine Egger
Silke Potthast
Martin Zoche
Andreas Wicki
Tarun Mehra

Frontiers in Oncology

doi 10.3389/fonc.2025.1613235

490 views

Review

Published on 17 Jun 2025

Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis

in Molecular and Cellular Oncology

Izabela Krauze
Beata Greb-Markiewicz
Anna Kłopot
Kamila Maciejewska
Michał Bryk
Małgorzata Krzystek-Korpacka

Frontiers in Oncology

doi 10.3389/fonc.2025.1595913

874 views

Original Research

Accepted on 16 Jun 2025

Comparison of [ 18 F]AlF-NOTA-FAPI-04 PET/CT and [ 18 F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors Running head: [ 18 F]AlF-NOTA-FAPI-04 vs [ 18 F]FDG PET/CT for lymph node metastasis diagnosis in malignancies

in Molecular and Cellular Oncology

Wanjing Zhou
jiashun dai
Kai Zheng
xiang peng
yanyin zhang
chengzhi jiang
Yang Jian
hui ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1605568

144 views

Methods

Accepted on 13 Jun 2025

Machine Learning-Based Single-Sample Molecular Classifier for Cancer Grading

in Molecular and Cellular Oncology

Zoia Antysheva
Nikita Kotlov
Mariia V Guryleva
Ivan Valiev
Viktor Svekolkin
Anna Belozerova
Sheila T Yong
Dmitry Tabakov
Alexander Bagaev
Vladimir Kushnarev

Frontiers in Oncology

doi 10.3389/fonc.2025.1617898

192 views

Case Report

Published on 12 Jun 2025

Neuroepithelial tumors of the central nervous system with EWSR1::PATZ1 fusion: a case report and literature review

in Molecular and Cellular Oncology

João Felipe Lima Feldmann
João Henrique Lima Feldmann
Felipe Sales Canedo
Felipe Cicci Farinha Restini
Romulo Loss Mattedi
Luiz Guilherme Cernaglia A. de Lima
Olavo Feher

Frontiers in Oncology

doi 10.3389/fonc.2025.1604479

692 views

Original Research

Published on 10 Jun 2025

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in lung carcinoid patients after receiving curative surgery. A multicentre study

in Molecular and Cellular Oncology

Nicola Tamburini
Beatrice Aramini
Ilaria Potenza
Francesco Bagolini
Danila Azzolina
Fares Shamshoum
Federico Rea
Franco Stella
Giampiero Dolci
Enrica Pellizzer

Frontiers in Oncology

doi 10.3389/fonc.2025.1585433

669 views